Biohaven Ltd [NYSE: BHVN] loss -4.25% or -1.87 points to close at $42.16 with a heavy trading volume of 3623166 shares.
The daily chart for BHVN points out that the company has recorded 51.00% gains over the past six months.
If we look at the average trading volume of 1.19M shares, BHVN reached to a volume of 3623166 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Biohaven Ltd [BHVN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHVN shares is $59.22 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHVN stock is a recommendation set at 1.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Biohaven Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 16, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Buy. The new note on the price target was released on February 06, 2024, representing the official price target for Biohaven Ltd stock. Previously, the target price had yet another raise to $50, while H.C. Wainwright analysts kept a Buy rating on BHVN stock.
The Average True Range (ATR) for Biohaven Ltd is set at 3.22 The Price to Book ratio for the last quarter was 7.99, with the Price to Cash per share for the same quarter was set at 4.69.
Trading performance analysis for BHVN stock
Biohaven Ltd [BHVN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.18. With this latest performance, BHVN shares dropped by -25.97% in over the last four-week period, additionally plugging by 51.00% over the last 6 months – not to mention a rise of 199.01% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHVN stock in for the last two-week period is set at 29.33, with the RSI for the last a single of trading hit 22.49, and the three-weeks RSI is set at 35.03 for Biohaven Ltd [BHVN]. The present Moving Average for the last 50 days of trading for this stock 51.83, while it was recorded at 45.56 for the last single week of trading, and 34.81 for the last 200 days.
Biohaven Ltd [BHVN]: A deeper dive into fundamental analysis
Biohaven Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.98 and a Current Ratio set at 7.98.
An analysis of Institutional ownership at Biohaven Ltd [BHVN]
The top three institutional holders of BHVN stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in BHVN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in BHVN stock with ownership which is approximately 5.8386%.
